Fundz

Polyrizon Ltd reported raising $4 Million in an initial SEC Form D filing, from an offering of $4 Million

PUBLIC · PLRZSep 03, 2026

Amount Raised

$4 Million

$4 Million sold, per SEC Form D (first sale Sep 3, 2026)
$4 Million per company press release (Sep 3, 2026)

Round Type

Post-IPO Equity

Center DistrictBiotechnologyHealth Care

Investors

Single Institutional Investor

Description

Polyrizon Ltd. has entered into definitive agreements for a registered direct offering and concurrent private placement, aiming for approximately $4.0 million in gross proceeds. The transactions involve the sale of Ordinary Shares and pre-funded warrants. The Company plans to utilize the net proceeds from these offerings to advance its development projects

Quick answer

Polyrizon Ltd raised $4 Million in a Post-IPO Equity round, dated September 3, 2026. Investors: Single Institutional Investor. Polyrizon Ltd is based in Center District, Israel.

How much did Polyrizon Ltd raise?
Polyrizon Ltd raised $4 Million in a Post-IPO Equity round on September 3, 2026.
Who invested in Polyrizon Ltd?
Single Institutional Investor is named as investors in this round.
What does Polyrizon Ltd do?
Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays.
Where is Polyrizon Ltd based and how big is it?
Polyrizon Ltd is based in Center District, Israel. Fundz records about 2 employees.
Who are the decision-makers at Polyrizon Ltd?
Fundz holds 2 contacts at Polyrizon Ltd, including the Chief People Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Polyrizon Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Vitonnix raised an undisclosed amount (Seed) on October 17, 2026.
  • GenSight Biologics raised $1.1M (Post-IPO Equity) on October 16, 2026.
  • Microbiotica raised $48M (Series C) on October 16, 2026.
  • Unravel Health raised $3.3M (Seed) on October 16, 2026.
  • Estuary Biotherapeutics raised $93M (Series A) on October 16, 2026.
  • Bioliberty raised $3.3M (Series A) on October 16, 2026.

Who to call at Polyrizon Ltd, and when

A new round usually means Polyrizon Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Polyrizon Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Polyrizon Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Polyrizon Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Polyrizon Ltd

Location

Center District, Israel

About

Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays. These sprays form a thin hydrogel-based shield that acts as a barrier against viruses and allergens. Polyrizon is focused on creating solutions that improve the intranasal delivery of drugs and alleviate allergy symptoms. Their proprietary hydrogel technology aims to provide rapid relief to those suffering from nasal allergies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Polyrizon Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDaphna A., Chief People Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Polyrizon Ltd's next move

See what Strategic adds

Polyrizon Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.